INSIGHTS CENTER

Regenerative Medicine Insights

Covering the latest developments in Japan's regenerative medicine field, including policy analysis, institutional guidance, stem cell therapy, iPS cell research, immune cell therapy, and practical guides for medical travel to Japan — helping you build an informed, professional perspective.

Visiting GINZA YR CLINIC in Tokyo Ginza: From Physician Background to Safety Compliance
FeaturedLatest Updates2026-02-05

Visiting GINZA YR CLINIC in Tokyo Ginza: From Physician Background to Safety Compliance

From the Ginza location and clinic interior, to Dr. Junya Higuchi's background as a University of Tokyo Medical Doctor, compliance practices, and an overview of stem cell, PRP, immune cell, and NAD+ treatment directions.

Read More
iPS Approval Doesn't Mean All Stem Cell Therapies Are Mature
Latest Updates2026-04-01

iPS Approval Doesn't Mean All Stem Cell Therapies Are Mature

The approval of iPS cell products is a milestone, but it doesn't mean all regenerative medicine programs in Japan are equally mature. Learn to distinguish media hype from actual medical progress.

Read More
What Is Japan's 'Conditional and Time-Limited Approval'? Don't Be Misled by the Word 'Approved'
Latest Updates2026-04-01

What Is Japan's 'Conditional and Time-Limited Approval'? Don't Be Misled by the Word 'Approved'

When you see a Japanese regenerative medicine product described as 'approved,' pause before celebrating. Understanding 'Conditional and Time-Limited Approval' is essential to truly grasping Japan's regulatory framework.

Read More
Japan's First iPS Cell Therapy Approval in 2026: What Does It Really Mean?
Latest Updates2026-04-01

Japan's First iPS Cell Therapy Approval in 2026: What Does It Really Mean?

In March 2026, Japan approved its first two iPS cell regenerative medicine products. This article provides a balanced analysis of the signals this milestone sends.

Read More
How to Verify If a Japanese Clinic's Regenerative Medicine Program Is Compliant
Latest Updates2026-04-01

How to Verify If a Japanese Clinic's Regenerative Medicine Program Is Compliant

Regenerative medicine in Japan requires proper authorization. Here's how to verify a clinic's registered regenerative medicine provision plan before your visit.

Read More
Where Is Japan's Regenerative Medicine Heading in 2026? Three Key Trends to Watch
Latest Updates2026-04-01

Where Is Japan's Regenerative Medicine Heading in 2026? Three Key Trends to Watch

Beyond the iPS approval — examining MHLW, AMED, and JSRM developments to identify three clear strategic directions in Japan's regenerative medicine landscape for 2026.

Read More
Beyond iPS: Organoids May Be Japan's Next Major Direction
Latest Updates2026-04-01

Beyond iPS: Organoids May Be Japan's Next Major Direction

Beyond iPS cells, organoids are emerging as a noteworthy new direction in Japan's regenerative medicine. An analysis incorporating the latest developments from Kyoto University.

Read More
How to Choose a Stem Cell Clinic in Tokyo: Three Dimensions to Avoid Pitfalls
Latest Updates2026-04-01

How to Choose a Stem Cell Clinic in Tokyo: Three Dimensions to Avoid Pitfalls

Looking into Tokyo stem cell clinics in 2026? Don't just rely on marketing. Evaluate from three angles: regulatory compliance, physician experience, and treatment boundaries.

Read More
Latest Updates2026-03-22

Understanding MHLW's Regenerative Medicine Updates: What Ordinary Readers Can Learn

An introduction to the MHLW's regenerative medicine update portal — its content characteristics and how general readers can use it to build foundational judgment.

Read More
What Are iPS Cells? Why They Matter in Japan's Regenerative Medicine
Latest Updates2026-03-22

What Are iPS Cells? Why They Matter in Japan's Regenerative Medicine

An introduction to the fundamental concepts of iPS cells and why they have remained at the core of Japan's regenerative medicine narrative.

Read More

CONTACT US

Contact Us

Want to learn more about institutions, treatment directions, or pre-visit preparation? Submit your inquiry and we'll respond as soon as possible.